Showing results (391-400 of 2,355) with videos related to

Sort By:
Pageof 236
Clinical Neuropharmacology|March 1, 1983
Cerebrospinal fluid GABA measurements: basic and clinical considerationsB V Manyam, T A Hare
Clinical Neuropharmacology|March 1, 1983
The current status of taurine in epilepsyL Durelli, R Mutani
Clinical Neuropharmacology|January 1, 1984
Ergot, the "jerks," and revivalsJ M Massey, E W Massey
Clinical Neuropharmacology|October 1, 1993
Parkinsonian syndrome in childhood after sodium valproate administrationM J Alvarez-Gomez, J Vaamonde, J Narbona, et al.
Clinical Neuropharmacology|June 1, 1997
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's diseaseS Ruggieri, M F De Pandis, A Bonamartini, et al.
Clinical Neuropharmacology|June 1, 1997
Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitorsD Aizenberg, S Gur, Z Zemishlany, et al.
Clinical Neuropharmacology|December 13, 2005
Venlafaxine and bladder functionMaurizio Inghilleri, A Conte, V Frasca, et al.
Clinical Neuropharmacology|December 13, 2005
A case of acute thallotoxicosis successfully treated with double-filtration plasmapheresisYing Ran Tian, Li Li Sun, Wen Wang, et al.
Clinical Neuropharmacology|November 26, 2009
Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosisGareth J Parry, Cecilia M P Rodrigues, Marcia M Aranha, et al.
Clinical Neuropharmacology|November 26, 2009
Pregabalin in the treatment of chronic migraine: an open-label studyElena P Calandre, Juan M Garcia-Leiva, Fernando Rico-Villademoros, et al.
Pageof 236